Form 4: Microbot Medical Inc. Director Acquires Stock Options
SEC Form 4 Filing
Tal Baruch Wenderow, a director of Microbot Medical Inc., acquired 10,000 stock options on January 28, 2025.
Summary
- On January 28, 2025, Tal Baruch Wenderow, a director at Microbot Medical Inc., acquired 10,000 stock options.
- The exercise price of these options is $1.93.
- The options become exercisable on December 17, 2025, and expire on January 28, 2035.
- Following this transaction, Wenderow directly owns 10,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of an insider transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a standard disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding the director's stake in the company.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of transaction: Director acquired stock options. |
| 01/28/2025 | Date of signature. |
| 12/17/2025 | Date the options become exercisable. |
| 01/28/2035 | Expiration date of the options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.